Management of cervical cancer: summary of SIGN guidelines

Por James, R M, Cruickshank, M E, Siddiqui, N
Publicado em 2008

Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women

Por Cotton, S C, Sharp, L, Seth, R, Masson, L F, Little, J, Cruickshank, M E, Neal, K, Waugh, N
Publicado em 2007

Human papillomavirus 16 infection in adenocarcinoma of the cervix

Por Chew, G K, Cruickshank, M E, Rooney, P H, Miller, I D, Parkin, D E, Murray, G I
Publicado em 2005

Is optimal first-line chemotherapy deliverable in all newly diagnosed ovarian cancers? A population-based study

Por McNally, O M, Delaney, E, Petty, R D, Cruickshank, M E, Hutcheon, A W, Parkin, D E
Publicado em 2003

The prognostic significance of micrometastases in node-negative squamous cell carcinoma of the vulva

Por Narayansingh, G V, Miller, I D, Sharma, M, Welch, C J, Sharp, L, Parkin, D E, Cruickshank, M E
Publicado em 2005

Psychosocial morbidity in women with abnormal cervical cytology managed by cytological surveillance or initial colposcopy: longitudinal analysis from the TOMBOLA randomised trial

Por Fielding, S., Rothnie, K., Gray, N. M., Little, J., Cruickshank, M. E., Neal, K., Walker, L. G., Whynes, D., Cotton, S. C., Sharp, L.
Publicado no Psychooncology (2016)

Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer

Por McFadyen, M C E, Cruickshank, M E, Miller, I D, McLeod, H L, Melvin, W T, Haites, N E, Parkin, D, Murray, G I
Publicado em 2001